HHS Removes HRT Breast Cancer Black Box Warning After 2025 Review
Updated
Updated · Dayton Daily News · Jun 1
HHS Removes HRT Breast Cancer Black Box Warning After 2025 Review
2 articles · Updated · Dayton Daily News · Jun 1
Late 2025, the U.S. Department of Health and Human Services dropped the breast-cancer black box warning on hormone replacement therapy after reviewing the scientific literature.
That review found the original signal was statistically non-significant and relied partly on a hormone formulation no longer commonly used; a key study also had an average participant age of 63, versus about 53 for menopause.
Product labels are now being revised to remove warnings tied to probable dementia, cardiovascular disease and breast cancer, while guidance still limits HRT use to women 60 or younger or within 10 years of menopause.
Estrogen-only risk language remains because it can thicken the uterine lining, and women with a uterus are advised to take estrogen with progestogen.
The change marks a broader reassessment of menopause care as new trials study sleep disruption, hot flashes, mood, cognition and delaying ovarian aging.
Beyond hot flashes, what powerful anti-aging benefits of HRT were hidden by the now-removed medical warning?
How did one flawed study derail women's health by demonizing vital hormone therapy for over twenty years?
FDA Removes Most Black Box Warnings from HRT in 2025: Transforming Menopause Care for Millions of Women
Overview
In November 2025, the FDA made a landmark decision to remove most 'black box' warnings from hormone replacement therapy (HRT) products, marking a new era in menopause care. This change was driven by extensive grassroots advocacy from women and medical professionals, reflecting a shift in scientific understanding of HRT's risks and benefits. The decision is expected to expand treatment options, encourage more open discussions, and support personalized care for millions of women. As a result, both patients and healthcare providers can look forward to improved access, reduced stigma, and more confidence in managing menopause symptoms.